SEC Filing Summary for Jacob Chacko

Jacob Chacko, a director at 4D Molecular Therapeutics, Inc. (FDMT), was granted 50,000 stock options on June 17, 2026. These options, with an exercise price of $9.42, are exercisable upon consummation of a Change in Control and vest over three years starting June 17, 2027, with full vesting by June 17, 2029. The grant was automatic under the company's non-employee director compensation program. Following the transaction, Chacko holds 50,000 shares.